Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epsin-1 is a highly conserved membrane-associated adaptor protein critical for clathrin-mediated endocytosis[1][2][3][6][7]. It binds to phosphoinositide lipids in the plasma membrane (primarily PtdIns(4,5)P2), clathrin, AP-2, and ubiquitinated membrane proteins via its distinct functional domains: an N-terminal ENTH domain mediating lipid binding and membrane curvature, multiple ubiquitin-interacting motifs (UIMs) capturing ubiquitinated cargo, and clathrin/adaptor binding motifs facilitating vesicular coat assembly[1][2][6][7]. Epsin-1 is required for force generation during invagination and scission of clathrin-coated pits, links actin to the endocytic machinery, and coordinates dynamics essential for vesicle formation[3][4][6]. Loss of EPN1 impairs endocytosis and can alter tumor growth and progression, underscoring functional relevance in membrane trafficking and implications for disease biology[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epsin-1 (EPN1).